CORBION NV (CRBN.AS) Stock Price, Forecast & Analysis
Europe - Euronext Amsterdam - AMS:CRBN - NL0010583399 - Common Stock
CRBN.AS Key Statistics, Chart & Performance
The current stock price of CRBN.AS is 19.27 EUR. In the past month the price increased by 9.12%. In the past year, price decreased by -12.33%.
CRBN.AS Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 1COV.DE | COVESTRO AG | N/A | 11.17B | ||
| SY1.DE | SYMRISE AG | 19.68 | 9.99B | ||
| AKZA.AS | AKZO NOBEL N.V. | 15.4 | 9.59B | ||
| AKU1.DE | AKZO NOBEL N.V. | 15.14 | 9.43B | ||
| SYENS.BR | SYENSQO SA | 21.62 | 7.30B | ||
| EVK.DE | EVONIK INDUSTRIES AG | 9.76 | 6.18B | ||
| AKE.PA | ARKEMA | 10.18 | 3.99B | ||
| UMI.BR | UMICORE | 13.41 | 3.73B | ||
| NVJP.DE | UMICORE | 13.39 | 3.73B | ||
| WCH.DE | WACKER CHEMIE AG | 154.19 | 3.46B | ||
| RBT.PA | ROBERTET SA | 18.76 | 1.91B | ||
| ACT.DE | ALZCHEM GROUP AG | 21.11 | 1.31B |
Related stock screener links
About CRBN.AS
Company Profile
Corbion NV engages in the development, production, sale, and distribution of ingredients for food and biochemicals. The company is headquartered in Amsterdam, Noord-Holland and currently employs 2,399 full-time employees. The company operates through two segments: Biobased Ingredients and Biobased Innovations. The Biobased Ingredients segment comprises the Food business division and the Biochemicals business division. The Food business division develops preservation ingredients and microbial spoilage prevention products for the baking, meat, dairy, confectionery and beverage industries, and the Biochemicals business division produces bio-based chemicals derived from renewable resources such as sugar or starch. The Biobased Innovations segment creates new biotechnology business platforms, such aspoly lactic acid (PLA). The firm operates production sites in the United States, Brazil, Spain, the Netherlands and Thailand, and markets its products through a global network of retail offices.
Company Info
CORBION NV
Piet Heinkade 127
Amsterdam NOORD-HOLLAND NL
Employees: 2407
Phone: 31205906911
CORBION NV / CRBN.AS FAQ
What does CRBN do?
Corbion NV engages in the development, production, sale, and distribution of ingredients for food and biochemicals. The company is headquartered in Amsterdam, Noord-Holland and currently employs 2,399 full-time employees. The company operates through two segments: Biobased Ingredients and Biobased Innovations. The Biobased Ingredients segment comprises the Food business division and the Biochemicals business division. The Food business division develops preservation ingredients and microbial spoilage prevention products for the baking, meat, dairy, confectionery and beverage industries, and the Biochemicals business division produces bio-based chemicals derived from renewable resources such as sugar or starch. The Biobased Innovations segment creates new biotechnology business platforms, such aspoly lactic acid (PLA). The firm operates production sites in the United States, Brazil, Spain, the Netherlands and Thailand, and markets its products through a global network of retail offices.
Can you provide the latest stock price for CORBION NV?
The current stock price of CRBN.AS is 19.27 EUR. The price decreased by -2.48% in the last trading session.
Does CRBN stock pay dividends?
CORBION NV (CRBN.AS) has a dividend yield of 3.24%. The yearly dividend amount is currently 0.71.
What is the ChartMill rating of CORBION NV stock?
CRBN.AS has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Where is CORBION NV (CRBN.AS) stock traded?
CRBN.AS stock is listed on the Euronext Amsterdam exchange.
CRBN.AS Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to CRBN.AS. When comparing the yearly performance of all stocks, CRBN.AS is a bad performer in the overall market: 68.2% of all stocks are doing better.
CRBN.AS Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to CRBN.AS. Both the profitability and the financial health of CRBN.AS get a neutral evaluation. Nothing too spectacular is happening here.
CRBN.AS Financial Highlights
Over the last trailing twelve months CRBN.AS reported a non-GAAP Earnings per Share(EPS) of 1.12. The EPS decreased by -68.99% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 5.11% | ||
| ROA | 4.55% | ||
| ROE | 9.12% | ||
| Debt/Equity | 0.39 |
CRBN.AS Forecast & Estimates
14 analysts have analysed CRBN.AS and the average price target is 23.33 EUR. This implies a price increase of 21.08% is expected in the next year compared to the current price of 19.27.
For the next year, analysts expect an EPS growth of 36.6% and a revenue growth -1.8% for CRBN.AS